DE69827466D1 - Geschmacksneutrale pharmazeutische zusammensetzungen - Google Patents

Geschmacksneutrale pharmazeutische zusammensetzungen

Info

Publication number
DE69827466D1
DE69827466D1 DE69827466T DE69827466T DE69827466D1 DE 69827466 D1 DE69827466 D1 DE 69827466D1 DE 69827466 T DE69827466 T DE 69827466T DE 69827466 T DE69827466 T DE 69827466T DE 69827466 D1 DE69827466 D1 DE 69827466D1
Authority
DE
Germany
Prior art keywords
taste
pharmaceutical compositions
neutral pharmaceutical
neutral
masks
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69827466T
Other languages
English (en)
Other versions
DE69827466T2 (de
Inventor
Hamilton Pitman
Stefan Lukas
Allen Mark Evans
Mark Dwyer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mayne Pharma Pty Ltd
Original Assignee
FH Faulding and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FH Faulding and Co Ltd filed Critical FH Faulding and Co Ltd
Application granted granted Critical
Publication of DE69827466D1 publication Critical patent/DE69827466D1/de
Publication of DE69827466T2 publication Critical patent/DE69827466T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
DE69827466T 1997-04-23 1998-04-23 Geschmacksneutrale pharmazeutische zusammensetzungen Expired - Lifetime DE69827466T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPO6371A AUPO637197A0 (en) 1997-04-23 1997-04-23 Taste-masked pharmaceutical compositions
AUPO637197 1997-04-23
PCT/AU1998/000296 WO1998047493A1 (en) 1997-04-23 1998-04-23 Taste masked pharmaceutical compositions

Publications (2)

Publication Number Publication Date
DE69827466D1 true DE69827466D1 (de) 2004-12-16
DE69827466T2 DE69827466T2 (de) 2005-12-15

Family

ID=3800665

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69827466T Expired - Lifetime DE69827466T2 (de) 1997-04-23 1998-04-23 Geschmacksneutrale pharmazeutische zusammensetzungen

Country Status (7)

Country Link
EP (1) EP0935460B1 (de)
AT (1) ATE281830T1 (de)
AU (1) AUPO637197A0 (de)
CA (1) CA2252773C (de)
DE (1) DE69827466T2 (de)
ES (1) ES2227826T3 (de)
WO (1) WO1998047493A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2795962B1 (fr) 1999-07-08 2003-05-09 Prographarm Laboratoires Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif
US20040048814A1 (en) * 2000-09-22 2004-03-11 Francis Vanderbist Sustained release composition contraining clarithromycin
WO2003037303A1 (en) 2001-11-01 2003-05-08 Nektar Therapeutics Spray drying methods and compositions thereof
GB0219815D0 (en) * 2002-08-24 2002-10-02 Accentus Plc Preparation of small crystals
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
KR100508992B1 (ko) * 2003-03-31 2005-08-17 한국유나이티드제약 주식회사 쓴 맛을 개선한 클래리스로마이신 경구용 약제 조성물 및 그의 제조 방법
AU2004251623B2 (en) 2003-05-28 2010-03-18 Novartis Ag Spray drying of an alcoholic aqueous solution for the manufacture of a water-in-soluble active agentmicroparticle with a partial or complete amino acid and/or phospholipid coat
EP2340812A1 (de) 2009-12-18 2011-07-06 Ferring International Center S.A. Granulat für pharmazeutische Präparate sowie Verfahren und Vorrichtungen zu ihrer Herstellung
CN102614516A (zh) * 2012-04-25 2012-08-01 黑龙江大学 一种掩味乳酸锌粉末的制备方法
CN102603513B (zh) * 2012-04-25 2013-12-25 黑龙江大学 一种乳酸亚铁粉末的制备方法
MA54510A (fr) 2018-12-21 2022-03-30 Novo Nordisk As Procédé de séchage par pulvérisation de peptide glp-1

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US4760094A (en) * 1986-10-21 1988-07-26 American Home Products Corporation (Del.) Spray dried acetaminophen
US4771077A (en) * 1986-10-21 1988-09-13 American Home Products Corporation (Del.) Spray dried acetaminophen
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
JP3265680B2 (ja) * 1992-03-12 2002-03-11 大正製薬株式会社 経口製剤用組成物
AU2562197A (en) * 1996-04-23 1997-11-12 F.H. Faulding & Co. Limited Taste masked paracetamol compositions

Also Published As

Publication number Publication date
ATE281830T1 (de) 2004-11-15
EP0935460A4 (de) 1999-12-22
DE69827466T2 (de) 2005-12-15
AUPO637197A0 (en) 1997-05-15
CA2252773C (en) 2006-07-11
WO1998047493A1 (en) 1998-10-29
CA2252773A1 (en) 1998-10-29
ES2227826T3 (es) 2005-04-01
EP0935460A1 (de) 1999-08-18
EP0935460B1 (de) 2004-11-10

Similar Documents

Publication Publication Date Title
AP1748A (en) Chronotherapeutic dosage forms.
HRP20040323C1 (hr) Oralni oblici davanja propiverina ili njegovih farmaceutski prihvatljivih soli s produljenim oslobađanjem djelotvone supstance
HRP20010463B1 (en) Controlled release galantamine composition
MY125548A (en) Water soluble film for oral administration with instant wettability
DK0868912T3 (da) Anvendelse af redispergerbare polymerpulvere eller polymergranulater til coating af farmaceutiske eller agrokemiske applikationsformer
DE69942921D1 (de) Osmotische Dosierungsform mit verlängerter Wirkstoffabgabe
EA200600598A1 (ru) Лекарственные формы замедленного высвобождения
DK2332523T3 (da) Ensartede film til hurtigtopløsende doseringsform indeholdende smagsmaskerende præparater
IL152339A0 (en) Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
ATE239454T1 (de) Orale morphinzubereitung in teilchenform
TR199802108T2 (xx) �bandronat i�eren oral farmas�tik bir form�lasyon.
MY129406A (en) Taste masked liquid pharmaceutical compositions
DE60112888T2 (de) Antimikrobielles, schnelltrocknendes Desinfektionsaerosol
BR0103033A (pt) Partìculas farmacêuticas de sabor mascarado
DE69827466D1 (de) Geschmacksneutrale pharmazeutische zusammensetzungen
EP0835655A4 (de) Antibakterielles/bakterizides/antiseptisches mittel, dermatologische zubereitung und tensidzusammensetzung
EE200100151A (et) Toimeaine pulmonaalne kohaletoimetamine kuivpulbriga
CA2402791A1 (en) Pre-formed sheet devices for topical application comprising a benefit agent coated solid gel sheet
ATE220547T1 (de) Arzneimittelformulierung mit kontrollierter wirkstofffreisetzung
RS49831B (sr) Farmaceutske kompozicije tizoksanida i nitazoksanida
HUP9900365A3 (en) N-aryl-1,2,4-triazolin-5-on derivatives, preparation and use thereof, insecticide, arachnicide and nematocide compositions containing these compounds as active ingredients
DE60307819D1 (de) Venlafaxine Hydrochloridformulierungen mit verzögerter Freisetzung
DE69727385D1 (de) Benzophenanthridinalkaloid-enthaltende pestizide
WO2001087236A3 (en) Topical administration of pharmacological compositions for non-systemic treatment of pruritus
AU8387601A (en) Novel pharmaceutical composition for the topical application of water-insoluble and/or hardly water-soluble active agents

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: MAYNE PHARMA PTY LTD., MELBOURNE, VICTORIA, AU

8328 Change in the person/name/address of the agent

Representative=s name: WESTENDORP SOMMER, 80336 MUENCHEN